Skip to main content


Table 1 Participant timeline in REGATTA

From: Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) – a double-blind, randomized, controlled comparative effectiveness trial

Activity Patient Contact Baseline Follow-up
Day 0 1 2 3 4 5 6 7 28
Visit Number I         II
Screening X         
Informed Consent X         
Inclusion / Exclusion criteria X         
Medical History, Examination X         
Urine Testsa X         
Pregnancy Test X         
Drug Intakeb X X X X X X    
Symptom Assessment and Activity Impairment (Diary) X X X X X X X X  
Additional Antibiotic Courses   X X X X X X X X
Painkiller Intake   X X X X X X X X
Adverse Events and Complications   X X X X X X X X
Recurrent UTI (Questionnaire)          X
Return of Drug Packages          X
Phone Calls to Remind Patients (Diary, Drug Return, Questionnaire)   X       X X
  1. aMidstream urine for on-site dipstick test (leukocytes, nitrite, red blood cells) and for urine culture (pathogens and resistances)
  2. bDrug intake until all 30 tablets are finished (= 3 × 2 tablets uva-ursi daily for 5 days)